269 related articles for article (PubMed ID: 6161459)
1. The questionable use of hormone therapy in advanced carcinoma of the prostate.
Murphy GP; Slack NH
Urol Clin North Am; 1980 Oct; 7(3):631-8. PubMed ID: 6161459
[No Abstract] [Full Text] [Related]
2. Endocrine therapy in the management of advanced prostatic cancer: the case for early initiation of treatment.
Grayhack JT; Kozlowski JM
Urol Clin North Am; 1980 Oct; 7(3):639-43. PubMed ID: 7456176
[No Abstract] [Full Text] [Related]
3. Combination of hormonal and cytostatic treatment for advanced carcinoma of the prostate.
Servadio C
Prog Clin Biol Res; 1985; 185A():407-26. PubMed ID: 4034582
[No Abstract] [Full Text] [Related]
4. [Orchidectomy and oestrogen therapy of carcinoma of the prostate (author's transl)].
Straube W; Braun JS
Urologe A; 1974 Jul; 13(4 Pt A):198-201. PubMed ID: 4137442
[No Abstract] [Full Text] [Related]
5. Deferred hormone treatment in prostate cancer.
Hall RR
Prog Clin Biol Res; 1987; 243B():439-40. PubMed ID: 3659037
[No Abstract] [Full Text] [Related]
6. Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors.
Kraljić I; Tarle M
Prog Clin Biol Res; 1987; 243B():521-5. PubMed ID: 3659050
[No Abstract] [Full Text] [Related]
7. The EORTC Phase III trials in prostatic cancer.
Robinson MR; Smith PH; Macaluso MP; Sylvester R; de Voogt H
Prog Clin Biol Res; 1985; 185A():243-9. PubMed ID: 3898132
[No Abstract] [Full Text] [Related]
8. Delayed hormonal therapy in advanced prostatic cancer.
Zungri E; Salvador J; Chéchile G; Diaz I; Martinez E
Prog Clin Biol Res; 1987; 243B():441-7. PubMed ID: 3659038
[No Abstract] [Full Text] [Related]
9. French multicenter study on the use of estramustine phosphate versus diethylstilbestrol.
Hauchecorne J
Prog Clin Biol Res; 1987; 243B():229-34. PubMed ID: 3309983
[No Abstract] [Full Text] [Related]
10. The case for early combined hormonal and cytostatic treatment for metastatic prostatic carcinoma.
Servadio C
Prog Clin Biol Res; 1987; 243B():449-53. PubMed ID: 3659039
[No Abstract] [Full Text] [Related]
11. Carcinoma of the prostate.
Abercrombie GF
Ann R Coll Surg Engl; 1974 Jan; 54(1):16-21. PubMed ID: 4129191
[No Abstract] [Full Text] [Related]
12. Hormonal treatment of advanced disease: some newer aspects.
Griffiths K; Eaton CL; Harper ME; Turkes A; Peeling WB
Semin Oncol; 1994 Oct; 21(5):672-87. PubMed ID: 7939755
[No Abstract] [Full Text] [Related]
13. [Chemotherapy of advanced prostate cancer].
Murphy GP
Vopr Onkol; 1977; 23(12):26-38. PubMed ID: 146305
[No Abstract] [Full Text] [Related]
14. Endocrine treatment of cancer of the prostate.
Madsen PO; Pedersen JF; Knuth OE
Wis Med J; 1970 Jul; 69(7):177-81. PubMed ID: 4916084
[No Abstract] [Full Text] [Related]
15. Prostate cancer: metastatic.
Michaelson D; Talcott J; Smith M
Clin Evid; 2002 Jun; (7):804-11. PubMed ID: 12230706
[No Abstract] [Full Text] [Related]
16. Is there a best endocrine management of prostatic carcinoma?
Robinson MR
Prog Clin Biol Res; 1988; 269():147-58. PubMed ID: 2969114
[No Abstract] [Full Text] [Related]
17. A randomized double blind crossover trial of diethylstilbestrol (DES) and estramustine phosphate (Emcyt) for stage D prostatic carcinoma.
Benson RC; Gill GM; Cummings KB
Semin Oncol; 1983 Sep; 10(3 Suppl 3):43-5. PubMed ID: 6364366
[No Abstract] [Full Text] [Related]
18. Hormonal therapy: the benefits of postponed initiation.
Cockburn AG
Urology; 1984 Nov; 24(5 Suppl):24-6. PubMed ID: 6388093
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of prostate volume by ultrasound in hormonally treated prostate cancer.
Brandt B; Menu G; el Khansa A; Lardennois B
Prog Clin Biol Res; 1987; 243B():13-9. PubMed ID: 3309979
[No Abstract] [Full Text] [Related]
20. Management of relapsed prostatic carcinoma following primary treatment.
Newling DW
Eur Urol; 1993; 24 Suppl 2():87-93. PubMed ID: 7505234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
